Data / Form D filings / Cotinga Pharmaceuticals Inc.
Cotinga Pharmaceuticals Inc.: Form D filings
Cotinga Pharmaceuticals Inc., a biotechnology company in London, Ontario, Canada, filed 13 Form D notices with the SEC between 2013 and 2018. The latest, on May 15, 2018, reports $1.6 million sold of a $1.6 million offering to 6 investors.
Find out what Cotinga Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 230B, THE MOGENSON CENTRE, 100 COLLIP CIRCLE, London, Ontario, Canada, N6G 4
- Phone
- (519) 858-5157
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1585808
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2018 | New notice | $1,580,439 | $1,580,439 | $0 | 6 | May 3, 2018 | sec.gov |
| May 24, 2017 | Amendment | $570,000 | $0 | $570,000 | 2 | Apr 11, 2014 | sec.gov |
| Jun 10, 2016 | Amendment | $570,000 | $0 | $570,000 | 2 | Apr 11, 2014 | sec.gov |
| May 27, 2016 | New notice | $17,415 | $0 | $17,415 | 1 | Apr 26, 2016 | sec.gov |
| May 27, 2016 | New notice | $1,800,527 | $1,100,000 | $700,527 | 1 | Mar 29, 2016 | sec.gov |
| May 27, 2016 | New notice | $29,085 | $0 | $29,085 | 3 | Mar 20, 2015 | sec.gov |
| Aug 18, 2015 | New notice | $23,453 | $13,796 | $9,657 | 1 | Jul 31, 2015 | sec.gov |
| May 8, 2015 | Amendment | $570,000 | $0 | $570,000 | 2 | Apr 11, 2014 | sec.gov |
| Sep 25, 2014 | Amendment | $6,101 | $0 | $6,101 | 1 | Aug 28, 2013 | sec.gov |
| Sep 25, 2014 | Amendment | $144,900 | $45,758 | $99,142 | 1 | Aug 28, 2013 | sec.gov |
| May 6, 2014 | New notice | $570,000 | $285,000 | $285,000 | 2 | Apr 11, 2014 | sec.gov |
| Sep 9, 2013 | New notice | $6,101 | $0 | $6,101 | 1 | Aug 28, 2013 | sec.gov |
| Sep 4, 2013 | New notice | $144,900 | $45,758 | $99,142 | 1 | Aug 28, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DAVID S SANDERSON | Director | |
| JOHN S YOO | Director | |
| GENE KELLY | Executive Officer | |
| JOHN C DRAKE | Director | |
| ALISON SILVA | Executive Officer, Director | |
| DOUGLAS S ALEXANDER | Director |
Every Form D from the week of May 14, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cotinga Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.